Cancer Deaths vs Research Funding

PANCREATIC CANCER IS DEADLY BUT RESEARCH GETS LITTLE CASH LUNG BOWEL BREAST PROSTATE PANCREAS OESOPHAGEAL STOMACH BLADDER NON-HODGKIN'S LYMPHOMA LEUKAEMIA 22% 10.3% 7.7% 6.5% 5% 4.8% 3.3% 3.2% 2.8% 2.8% 1.2 1.6% 2.5% 5.5% 3.9% 7.8% 10.4% 19.6% 15.2% PERCENTAGE OF MAJOR FUNDERS' SPEND ON SPECIFIC CANCER TYPES THE HUMAN COST PERCENTAGE OF TOTAL CANCER DEATHS IN UK SURGERY OFFERS HOPE MEN WOMEN 14,001 4,084 18.2 NUMBER OF NEW CASES (UK 2008) 10.5 INCIDENCE RATE PER 100,000 POPULATION OF PATIENTS ARE ELIGIBLE FOR CURATIVE SURGERY 10% AND HAVE A GREATER CHANCE OF SURVIVAL 13,807 3,974 $7.8 NUMBER OF DEATHS (UK 2008) SURVIVAL RATE MORTALITY RATE PER 100,000 POPULATION 19.9 Survival rates for some types of cancer have improved significantly over the past 20 years ONE-YEAR SURVIVAL RATE (ADULT PATIENTS DIAGNOSED 2004-2006, ENGLAND) i16% i17% Pancreatic cancer is the only cancer that has seen no improvement in its long-term survival rate over the last 40 years FIVE-YEAR SURVIVAL RATE (ADULT PATIENTS DIAGNOSED 2001-2006, ENGLAND) 13% 13%